andrew ingersoll - national e-health transition authority (nehta) - australian medicines terminology...
TRANSCRIPT
National E-Health Transition Authority www.nehta.gov.au1
Australian Medicines
Terminology (AMT) in eMM:
need for innovation and
research
5th Annual eMedication Management Conference
16 March 2016
Andrew Ingersoll Benefits and Evaluation Specialist
2 National E-Health Transition Authority www.nehta.gov.au
• AMT as an enabler
• Ongoing implementations
• Need for innovation and research
Agenda
3 National E-Health Transition Authority www.nehta.gov.au
Health system efficiencies
Population health outcomes
Why are we here?
AMT as an enabler
Avoidable adverse drug
events
Avoidable hospitalisations
4 National E-Health Transition Authority www.nehta.gov.au
Computer and human readable language
AMT as an enabler
SNOMED CT
SNOMED CT-AU
AMT
5 National E-Health Transition Authority www.nehta.gov.au
• Improved data quality
• Reduced time to sourcing information
• Reduction in transcription errors
• Capacity for analytics
• Intra and inter-organisational CDS
Benefits of AMT
AMT as an enabler
6 National E-Health Transition Authority www.nehta.gov.au
Concepts
• Are objects of thought
• Designated by a unique code ConceptID
• Designed to cover medicines and their defining attributes
12809011000036105Amoxil 250 mg
capsule: hard, 20 27698011000036106acyclovir 200 mg tablet,
50 tablets(medicinal product pack)
21821011000036104codeine
(medicinal product) 35975011000036105Actonel Combi D (trade product)
AMT as an enabler
7 National E-Health Transition Authority www.nehta.gov.au
AMT as an enabler
12809011000036105Amoxil 250 mg
capsule: hard, 20
21821011000036104codeine
(medicinal product)
35975011000036105Actonel Combi D (trade product)
8 National E-Health Transition Authority www.nehta.gov.au
“the Commonwealth and all states and territories have a mutual interest in developing a national eHealth capability that will improve health outcomes and health system efficiency, and which is underpinned by national specifications, standards, services and infrastructure.”
Government commitment
Ongoing implementations
9 National E-Health Transition Authority www.nehta.gov.au
• Migration to AMT
• AMT integrated into priority specifications and services; and
• Taking steps towards incorporating AMT into new clinical systems and upgrades
AMT called out as a priority
Ongoing implementations
10 National E-Health Transition Authority www.nehta.gov.au
Ongoing implementations
WA
NTQLD
NSW
ACTVIC
TAS
SA
12809011000036105Amoxil 250 mg
capsule: hard, 20
35975011000036105Actonel Combi D (trade product)
11 National E-Health Transition Authority www.nehta.gov.au
• Eliminate paper and free text
• Eliminate silos with eHealth solutions
• Extractable data
• eHealth infrastructure as platforms for innovation
• Positively disrupt workflows
Changes required
Ongoing implementations
12 National E-Health Transition Authority www.nehta.gov.au
• Assess and validate assumptions
• Inform resource decisions
• Communicate successes
• Measure ROI
• Secure commitment to ongoing funding
Why measure?
Need for innovation and research
13 National E-Health Transition Authority www.nehta.gov.au
Longitudinal – impact of eHealth solutions over time
Retrospective – impact of past eHealth implementations
Baseline – pre implementation, gain ability to measure the impact after an upcoming implementation
Research with impact
Need for innovation and research
14 National E-Health Transition Authority www.nehta.gov.au
• AMT is the language of medicines
• AMT enables cross sector clinical decision support
• Innovation and research are required
Review
12809011000036105Amoxil 250 mg
capsule: hard, 20
21821011000036104codeine
(medicinal product)
35975011000036105Actonel Combi D (trade product)
15 National E-Health Transition Authority www.nehta.gov.au
• Baseline study
• Aged Care and General Practice
• Role for AMT in cross sector medicine information exchange
GRACE Med
